180698-19-5,MFCD02093529
Catalog No.:AA00225H

180698-19-5 | 1-Biphenyl-4-yl-piperazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$45.00   $31.00
- +
250mg
98%
in stock  
$64.00   $45.00
- +
1g
97%
in stock  
$140.00   $98.00
- +
5g
98%
in stock  
$627.00   $439.00
- +
10g
97%
in stock  
$1,091.00 $764.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00225H
Chemical Name:
1-Biphenyl-4-yl-piperazine
CAS Number:
180698-19-5
Molecular Formula:
C16H18N2
Molecular Weight:
238.3275
MDL Number:
MFCD02093529
SMILES:
N1CCN(CC1)c1ccc(cc1)c1ccccc1
Properties
Properties
 
BP:
422°C at 760 mmHg  
Form:
Solid  
MP:
142-143 °C  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
234  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.7  

Downstream Synthesis Route

[1]Locationinpatent:experimentalpartGhosh,Balaram;Antonio,Tamara;Gopishetty,Bhaskar;Reith,Maarten;Dutta,Aloke[BioorganicandMedicinalChemistry,2010,vol.18,#15,p.5661-5674]

[2]Huang,Yiyun;Kegeles,LawrenceS.;Bae,Sung-A;Hwang,Dah-ren;Roth,BryanL.;Savage,JasonE.;Laruelle,Marc[BioorganicandMedicinalChemistryLetters,2001,vol.11,#11,p.1375-1377]

[3]Dholkawala,Fahd;Voshavar,Chandrashekhar;Dutta,AlokeK.[EuropeanJournalofPharmaceuticsandBiopharmaceutics,2016,vol.103,p.62-70]

5654-92-2    180698-19-5   
3-(4-biphenyl-4-yl-piperazin-1-ylmethyl)-1<i>H</i>-pyrrolo2,3-<i>b</i>pyridine 

[1]Huang,Yiyun;Kegeles,LawrenceS.;Bae,Sung-A;Hwang,Dah-ren;Roth,BryanL.;Savage,JasonE.;Laruelle,Marc[BioorganicandMedicinalChemistryLetters,2001,vol.11,#11,p.1375-1377]

32315-10-9    148546-78-5    180698-19-5   
4-biphenyl-4-yl-piperazine-1-carboxylicacid4-methoxy-3-(4-methyl-piperazin-1-yl)-phenyl-amide 

[1]Huang,Yiyun;Bae,Sung-A.;Roth,BryanL.;Laruelle,Marc[BioorganicandMedicinalChemistryLetters,2005,vol.15,#21,p.4786-4789]

701213-98-1    180698-19-5   
C27H22FN7O2 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2007/249579,2007,A1Locationinpatent:Page/Pagecolumn45;47

[1]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US6818644,2004,B1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:180698-19-5 Molecular Formula|180698-19-5 MDL|180698-19-5 SMILES|180698-19-5 1-Biphenyl-4-yl-piperazine
Catalog No.: AA00225H
180698-19-5,MFCD02093529
180698-19-5 | 1-Biphenyl-4-yl-piperazine
Pack Size: 100mg
Purity: 97%
in stock
$45.00 $31.00
Pack Size: 250mg
Purity: 98%
in stock
$64.00 $45.00
Pack Size: 1g
Purity: 97%
in stock
$140.00 $98.00
Pack Size: 5g
Purity: 98%
in stock
$627.00 $439.00
Pack Size: 10g
Purity: 97%
in stock
$1,091.00 $764.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00225H
Chemical Name: 1-Biphenyl-4-yl-piperazine
CAS Number: 180698-19-5
Molecular Formula: C16H18N2
Molecular Weight: 238.3275
MDL Number: MFCD02093529
SMILES: N1CCN(CC1)c1ccc(cc1)c1ccccc1
Properties
BP: 422°C at 760 mmHg  
Form: Solid  
MP: 142-143 °C  
Storage: Inert atmosphere;Room Temperature;  
Complexity: 234  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.7  
Downstream Synthesis Route
110-85-0    92-66-0    180698-19-5 

[1]Locationinpatent:experimentalpartGhosh,Balaram;Antonio,Tamara;Gopishetty,Bhaskar;Reith,Maarten;Dutta,Aloke[BioorganicandMedicinalChemistry,2010,vol.18,#15,p.5661-5674]

[2]Huang,Yiyun;Kegeles,LawrenceS.;Bae,Sung-A;Hwang,Dah-ren;Roth,BryanL.;Savage,JasonE.;Laruelle,Marc[BioorganicandMedicinalChemistryLetters,2001,vol.11,#11,p.1375-1377]

[3]Dholkawala,Fahd;Voshavar,Chandrashekhar;Dutta,AlokeK.[EuropeanJournalofPharmaceuticsandBiopharmaceutics,2016,vol.103,p.62-70]

5654-92-2    180698-19-5   
3-(4-biphenyl-4-yl-piperazin-1-ylmethyl)-1<i>H</i>-pyrrolo2,3-<i>b</i>pyridine 

[1]Huang,Yiyun;Kegeles,LawrenceS.;Bae,Sung-A;Hwang,Dah-ren;Roth,BryanL.;Savage,JasonE.;Laruelle,Marc[BioorganicandMedicinalChemistryLetters,2001,vol.11,#11,p.1375-1377]

32315-10-9    148546-78-5    180698-19-5   
4-biphenyl-4-yl-piperazine-1-carboxylicacid4-methoxy-3-(4-methyl-piperazin-1-yl)-phenyl-amide 

[1]Huang,Yiyun;Bae,Sung-A.;Roth,BryanL.;Laruelle,Marc[BioorganicandMedicinalChemistryLetters,2005,vol.15,#21,p.4786-4789]

701213-98-1    180698-19-5   
C27H22FN7O2 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2007/249579,2007,A1Locationinpatent:Page/Pagecolumn45;47

327030-32-0    180698-19-5 

[1]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US6818644,2004,B1

Building Blocks More >
18099-59-7
18099-59-7
Ethanone, 1-[4-(decyloxy)phenyl]-
AA0022G9 | MFCD00216911
181231-67-4
181231-67-4
Silanamine, 1-butyl-N,N,1,1-tetramethyl-
AA0022O2 | MFCD00674106
18171-19-2
18171-19-2
3-Chloropropylmethyldimethoxysilane
AA0022Z9 | MFCD00053912
182057-85-8
182057-85-8
Benzenepropanol, γ-amino-4-(phenylmethoxy)-
AA00238G | MFCD04124850
182344-13-4
182344-13-4
3-Chloro-4-hydroxyphenylboronic acid
AA0023LK | MFCD09258739
18264-71-6
18264-71-6
Benzenamine, 2-nitro-N-(2-nitrophenyl)-
AA0023YM | MFCD01861530
18312-57-7
18312-57-7
Ethanol, 2,2'-(tridecylimino)bis-
AA0024CA | MFCD06252526
17664-93-6
17664-93-6
H-D-Leu-obzl tos
AA0024PG | MFCD00066116
17700-55-9
17700-55-9
N-(2,6-Dichloro-3-methylphenyl)acetamide
AA0024ZG | MFCD04067403
177480-81-8
177480-81-8
4-Bromo-2-chloro-5-fluorobenzoic acid
AA00259X | MFCD00236589
Submit
© 2017 AA BLOCKS, INC. All rights reserved.